526546 Stock Overview Provides contract testing and analytical services in India and internationally. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Choksi Laboratories Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Choksi Laboratories Historical stock prices Current Share Price ₹63.17 52 Week High ₹94.00 52 Week Low ₹38.32 Beta 0.16 1 Month Change -0.77% 3 Month Change -21.74% 1 Year Change -6.90% 3 Year Change 210.42% 5 Year Change 490.37% Change since IPO 6.44%
Recent News & Updates
Second quarter 2025 earnings released: EPS: ₹0.11 (vs ₹0.01 in 2Q 2024) Nov 15
Investor sentiment improves as stock rises 19% Nov 09
Choksi Laboratories Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 05
Investor sentiment deteriorates as stock falls 17% Oct 25
Investor sentiment improves as stock rises 17% Sep 11
Investor sentiment improves as stock rises 26% Aug 27 See more updates
Second quarter 2025 earnings released: EPS: ₹0.11 (vs ₹0.01 in 2Q 2024) Nov 15
Investor sentiment improves as stock rises 19% Nov 09
Choksi Laboratories Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 05
Investor sentiment deteriorates as stock falls 17% Oct 25
Investor sentiment improves as stock rises 17% Sep 11
Investor sentiment improves as stock rises 26% Aug 27
New minor risk - Share price stability Aug 26
First quarter 2025 earnings released: EPS: ₹0.60 (vs ₹0.51 in 1Q 2024) Aug 14
Choksi Laboratories Limited, Annual General Meeting, Sep 21, 2024 Aug 13
Choksi Laboratories Limited to Report Q1, 2025 Results on Aug 13, 2024 Aug 03
Investor sentiment improves as stock rises 21% Jul 31
New minor risk - Profit margin trend Jun 04
Full year 2024 earnings released: EPS: ₹1.59 (vs ₹4.61 in FY 2023) Jun 04
Choksi Laboratories Limited to Report Q4, 2024 Results on May 29, 2024 May 23
Now 20% undervalued Apr 30
Investor sentiment improves as stock rises 16% Apr 24
Investor sentiment improves as stock rises 23% Apr 09
New major risk - Share price stability Apr 01
Investor sentiment deteriorates as stock falls 16% Mar 12
Investor sentiment improves as stock rises 24% Feb 27
Now 20% undervalued after recent price drop Feb 05
Third quarter 2024 earnings released: EPS: ₹0.09 (vs ₹0.19 loss in 3Q 2023) Feb 04
Less than half of directors are independent Feb 01
Choksi Laboratories Limited to Report Q3, 2024 Results on Feb 03, 2024 Jan 28
New minor risk - Share price stability Nov 21
Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.08 in 2Q 2023) Nov 12
Investor sentiment improves as stock rises 16% Nov 09
Choksi Laboratories Limited to Report Q2, 2024 Results on Nov 10, 2023 Nov 04
First quarter 2024 earnings released: EPS: ₹0.51 (vs ₹0.43 in 1Q 2023) Aug 13
Choksi Laboratories Limited, Annual General Meeting, Sep 27, 2023 Aug 13
Choksi Laboratories Limited to Report Q1, 2024 Results on Aug 12, 2023 Aug 05
Investor sentiment improves as stock rises 31% Jul 18
Choksi Laboratories Limited Appoints Prakhar Dubey as Company Secretary and Compliance Officer Jul 06
Choksi Laboratories Limited Proposes the Resignation of Yash Gupta from the Post of Company Secretary and Compliance Officer Jul 01
Investor sentiment improves as stock rises 18% Jun 13
Full year 2023 earnings released: EPS: ₹4.61 (vs ₹0.30 in FY 2022) May 31 Choksi Laboratories Limited to Report Q4, 2023 Results on May 29, 2023
Investor sentiment improves as stock rises 22% Apr 21
Investor sentiment deteriorates as stock falls 19% Feb 28
Third quarter 2023 earnings released: ₹0.19 loss per share (vs ₹0.04 profit in 3Q 2022) Feb 14
Choksi Laboratories Limited to Report Q3, 2023 Results on Feb 13, 2023 Feb 04
Investor sentiment improves as stock rises 19% Feb 03
Investor sentiment improved over the past week Jan 20
Investor sentiment improved over the past week Dec 30
Less than half of directors are independent Nov 16
Choksi Laboratories Limited to Report Q2, 2023 Results on Nov 12, 2022 Nov 05
Investor sentiment improved over the past week Oct 10
Choksi Laboratories Limited Appoints Mr. Raghmendra Singh as an Independent Director Aug 20 Choksi Laboratories Limited Proposes Resignation of Directors
Choksi Laboratories Limited to Report Q4, 2022 Results on May 28, 2022 May 17
Insufficient new directors Apr 27
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 15
Second quarter 2022 earnings released: ₹0.75 loss per share (vs ₹0.54 loss in 2Q 2021) Nov 18
Second quarter 2022 earnings released: ₹0.75 loss per share (vs ₹0.54 loss in 2Q 2021) Nov 18
First quarter 2022 earnings released: ₹2.20 loss per share (vs ₹1.10 loss in 1Q 2021) Aug 18
Full year 2021 earnings released: ₹3.74 loss per share (vs ₹5.58 loss in FY 2020) Jul 06
New 90-day low: ₹8.93 Feb 17
Third quarter 2021 earnings released: ₹1.55 loss per share (vs ₹0.75 loss in 3Q 2020) Feb 12
Choksi Laboratories Limited to Report Q3, 2021 Results on Feb 10, 2021 Feb 04
New 90-day high: ₹11.51 Dec 04
Choksi Laboratories Limited to Report Q4, 2020 Results on Jul 30, 2020 Jul 26 Shareholder Returns 526546 IN Professional Services IN Market 7D -1.5% -3.3% -4.2% 1Y -6.9% 28.8% 19.1%
See full shareholder returns
Return vs Market: 526546 underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility Is 526546's price volatile compared to industry and market? 526546 volatility 526546 Average Weekly Movement 9.0% Professional Services Industry Average Movement 6.2% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 526546's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 526546's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical and dyes, cosmetics, and construction material analysis. The company’s instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory.
Show more Choksi Laboratories Limited Fundamentals Summary How do Choksi Laboratories's earnings and revenue compare to its market cap? 526546 fundamental statistics Market cap ₹440.00m Earnings (TTM ) ₹12.41m Revenue (TTM ) ₹399.14m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 526546 income statement (TTM ) Revenue ₹399.14m Cost of Revenue ₹191.89m Gross Profit ₹207.25m Other Expenses ₹194.84m Earnings ₹12.41m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 1.78 Gross Margin 51.92% Net Profit Margin 3.11% Debt/Equity Ratio 124.5%
How did 526546 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/21 00:32 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Choksi Laboratories Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
